AR060847A1 - Formulacion a base de calendula, aloe y centella. - Google Patents

Formulacion a base de calendula, aloe y centella.

Info

Publication number
AR060847A1
AR060847A1 ARP070101909A ARP070101909A AR060847A1 AR 060847 A1 AR060847 A1 AR 060847A1 AR P070101909 A ARP070101909 A AR P070101909A AR P070101909 A ARP070101909 A AR P070101909A AR 060847 A1 AR060847 A1 AR 060847A1
Authority
AR
Argentina
Prior art keywords
glycolic extract
parts
calendula
aloe
centella
Prior art date
Application number
ARP070101909A
Other languages
English (en)
Original Assignee
Spannagel Lucia Antonia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spannagel Lucia Antonia filed Critical Spannagel Lucia Antonia
Priority to ARP070101909A priority Critical patent/AR060847A1/es
Priority to EP08380137A priority patent/EP2008661A3/en
Publication of AR060847A1 publication Critical patent/AR060847A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

La formulacion comprende entre 1 y 98 partes de extracto glicolico de caléndula officinalis, entre 1 y 98 partes de extracto glicolico de aloe vera y entre 1 y 98 partes de extracto glicolico de centella asiaticae. La formulacion conforma una emulsion a partir de entre un 4 y un 8% de extracto glicolico de caléndula, entre 4 y un 8% de extracto glicolico de aloe y entre un 5,5 y un 9% de extracto glicolico de centella adicionados a una crema base no ionica que a su vez comprende una fase oleosa donde se incorporan entre un 6,5 y un 12% de cera autoemulsionable no ionica; entre un 3,2 y un 5,8% de ácido esteárico de triple presion, entre un 4 y un 6,4% de vaselina solida y entre 7,6 y un 9,7% de vaselina líquida. A su vez, la fase acuosa comprende entre un 7 y un 10,4% de glicerina; entre 0,1 y 0,8% de imidozolindil urea; entre un 1,6 y un 3,3% de conservante universal; entre un 0,7 y un 1,5% de polietilenglicol 400; entre 0,35 y 0,78% de Twen 80. Por ultimo la emulsion comprende el agregado de agua desmineralizada hasta completar 100g. de producto.
ARP070101909A 2007-05-03 2007-05-03 Formulacion a base de calendula, aloe y centella. AR060847A1 (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ARP070101909A AR060847A1 (es) 2007-05-03 2007-05-03 Formulacion a base de calendula, aloe y centella.
EP08380137A EP2008661A3 (en) 2007-05-03 2008-05-05 Formulation based on marigold aloe and centellae

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP070101909A AR060847A1 (es) 2007-05-03 2007-05-03 Formulacion a base de calendula, aloe y centella.

Publications (1)

Publication Number Publication Date
AR060847A1 true AR060847A1 (es) 2008-07-16

Family

ID=39681055

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101909A AR060847A1 (es) 2007-05-03 2007-05-03 Formulacion a base de calendula, aloe y centella.

Country Status (2)

Country Link
EP (1) EP2008661A3 (es)
AR (1) AR060847A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113841658A (zh) * 2021-10-13 2021-12-28 昆明医科大学 一种牙周炎模型的快速建立方法及治疗药物

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA015246B1 (ru) 2006-02-21 2011-06-30 Мэри Кэй, Инк. Неводная композиция стабильной аскорбиновой кислоты и способ ее приготовления
US10835555B2 (en) 2007-02-26 2020-11-17 Heartbeet Ltd Compositions of nitrates and methods of use thereof
US11759477B2 (en) 2007-02-26 2023-09-19 Heartbeet Ltd. Compositions of nitrates and methods of use thereof
US10842813B2 (en) 2007-02-26 2020-11-24 Heartbeet Ltd Compositions of nitrates and methods of use thereof
US10406118B2 (en) 2007-02-26 2019-09-10 Jon Lundberg Use of nitrites and nitrates and compositions containing these
US10821132B2 (en) 2007-02-26 2020-11-03 Heartbeet Ltd Compositions of nitrates and methods of use thereof
TWI473614B (zh) 2008-05-29 2015-02-21 Kyowa Hakko Kirin Co Ltd Anti-analgesic inhibitors
CA2754565C (en) 2009-03-04 2020-12-29 Regenera Pharma Ltd. Compositions of polymeric myrcene
PL2403505T3 (pl) 2009-03-04 2017-06-30 Regenera Pharma Ltd. Terapeutyczne zastosowania frakcji gumy mastyksowej
CN104138487B (zh) 2009-05-04 2018-10-12 库克岛医学技术有限公司 用于处理伤口、皮肤疾病和脱发的滨豇豆、椰子树或榄仁树提取物中的一种或多种
ES2350075B1 (es) 2009-05-11 2011-11-10 Maria Pilar Mateo Herrero Composicion microencapsulada a base de olea europaea saponificada, suuso y su procedimiento de obtencion.
CN102803281B (zh) 2009-05-28 2015-08-19 丽格诺创新有限公司 来自软木原料的天然木素的衍生物
US20100323031A1 (en) 2009-06-22 2010-12-23 Glykon Technologies Group, Llc Synergistic combination to enhance blood glucose and insulin metabolism
BR112012001488A2 (pt) 2009-07-20 2019-10-08 Nestec Sa processos de atenuação de perda de status funcional.
SG10201404811SA (en) 2009-08-12 2014-09-26 Munisekhar Medasani Picrorhiza kurroa extract for prevention, elimination and treatment of dna based viruses in humans and in biotech industry
JP5951489B2 (ja) 2009-10-16 2016-07-13 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅ ＬＬＣ 組成物
WO2011069214A1 (en) 2009-12-10 2011-06-16 Cimtech Pty Limited Methods and compositions for bone and cartilage repair
PL2611454T3 (pl) 2010-09-02 2015-09-30 Naturland Magyarorszag Termelo Es Kereskedelmi Kft Doustny preparat zawierający histaminazę pochodzenia roślinnego, oporną na pepsynę i trypsynę oraz sposób jego wytwarzania
US20120264776A1 (en) 2011-03-31 2012-10-18 Jitendra Krishan Somani Menthol liquids composition
WO2012141018A1 (ja) 2011-04-15 2012-10-18 ライオン株式会社 組成物、及び糖代謝改善剤、並びに糖代謝改善方法
EP2699095A4 (en) 2011-04-20 2015-04-15 Nestec Sa METHODS AND COMPOSITIONS THAT CAN BE USED TO PREVENT AND TREAT HYPERLEPTINEMIA
US9951148B2 (en) 2011-04-29 2018-04-24 Nutrileads B.V. Method for isolation of polysaccharides
CN103619344B (zh) 2011-05-16 2017-09-12 维特食品加工有限公司 膳食补充剂
ES2655642T3 (es) 2011-05-16 2018-02-21 Ulrike Nuber Terapias contra el cáncer novedosas y métodos
EP2709642A4 (en) 2011-05-16 2015-08-26 Haus Bioceuticals Inc THERAPEUTIC COMPOSITIONS OF CERTAIN HERBAL FORMULATIONS AND USES THEREOF
ITMI20110887A1 (it) 2011-05-19 2012-11-20 Difass Internat Srl Composizioni comprendenti resveratrolo e olio essenziale di chiodi di garofano per il trattamento del prurito
FR2975593B1 (fr) 2011-05-27 2013-05-10 Oreal Composition comprenant un alcoxysilane et un amidon modifie et son utilisation en cosmetique
KR20120133133A (ko) 2011-05-30 2012-12-10 한국 한의학 연구원 생약 추출물 또는 이의 유산균 발효물을 포함하는 호흡기 질환의 예방 또는 치료용 조성물
EP2532355A1 (en) 2011-06-06 2012-12-12 Nestec S.A. Chicory for prevention and treatment of neurodegeneration
WO2012175682A2 (en) 2011-06-23 2012-12-27 L'oreal Cosmetic composition comprising at least one particular amphoteric polymer and at least one particular conditioning agent
ME01019B (me) 2012-03-27 2012-10-20 Nurkovic Suljo Promelem
CN111671710A (zh) * 2020-07-31 2020-09-18 重庆康视美科技有限公司 一种抗蓝光护眼护肤液及其制备方法、使用方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57145806A (en) 1981-03-06 1982-09-09 Norio Tochimoto Ointment base for skin made from incrustation of hot-spring water and extract from plant of genus aloe as raw material
US4725438A (en) 1986-05-29 1988-02-16 Leazer Billie S Aloe vera ointment
JPH02117618A (ja) 1988-10-26 1990-05-02 Shigeno Yoshizawa 火傷治療薬
IT1247512B (it) 1991-04-23 1994-12-17 Antonio Carmelo Nucera Composizioni per la terapia topica delle ustioni
US5266330A (en) 1992-06-18 1993-11-30 Cannon Karen A Method for treating pressure ulcers using calendula
FR2696932B1 (fr) * 1992-10-19 1994-11-25 Sederma Sa Nouvelles compositions à usage cosmétique consistant de l'association d'un filtrat de fermentation et d'extraits de plantes.
CN1120565A (zh) * 1995-07-26 1996-04-17 青岛大学科技教育开发公司食品科学研究所 从万寿菊花提取叶黄素树脂食用色素的方法
ATE211917T1 (de) 1996-05-10 2002-02-15 Nino Shikhashvili Gruene salbe
US5843467A (en) 1996-07-15 1998-12-01 Ambroziewigz; Wieslaw Topical ointment consisting of animal fat, plantain lancetowata, and calendula and methods of producing the same
JP4299374B2 (ja) * 1996-10-08 2009-07-22 高砂香料工業株式会社 細胞賦活剤及びその応用
RU2149009C1 (ru) 1996-11-27 2000-05-20 Гаврилин Олег Николаевич Средство для лечения трофических язв
RU2128500C1 (ru) 1997-01-17 1999-04-10 Варфоломеев Борис Иванович Мазь б.и.варфоломеева для лечения ожогов
RU2138277C1 (ru) 1997-05-07 1999-09-27 Дармограй Василий Николаевич Средство для комплексного лечения ожоговых и постравматических ран
CN1176134A (zh) 1997-09-17 1998-03-18 王素艳 芦荟活性胶
DE19844255A1 (de) 1998-09-26 2000-03-30 Rainer Loges Lotina skin repair
CN1121233C (zh) 1998-12-07 2003-09-17 成都赛维芦荟制品有限公司 芦荟凝胶粉的制备方法
US6261603B1 (en) * 1999-05-11 2001-07-17 Mcelwain Elizena A. Skin cream
CN1163269C (zh) 1999-12-09 2004-08-25 上海瑞金医学服务中心 含有芦荟的药用组合物,其制备方法及其应用
CN1157210C (zh) 1999-12-09 2004-07-14 上海瑞金医学服务中心 含有芦荟的药用组合物、其制备方法及其应用
US6228387B1 (en) * 2000-01-27 2001-05-08 Murray Borod Integrated comprehensive hemorrhoid treatment compositions and regimen
CN1167430C (zh) 2000-03-15 2004-09-22 车国庆 一种广谱抗菌治疗深度烧烫伤的药膏
JP4589483B2 (ja) * 2000-05-12 2010-12-01 花王株式会社 ニキビ予防治療剤
CN1096270C (zh) 2000-10-16 2002-12-18 张彦英 无疤痕烫伤膏
AU2001297591A1 (en) 2000-11-01 2002-09-19 Zengen, Inc. A sunburn treatment and sunburn prevention method
CN1141117C (zh) 2000-12-22 2004-03-10 陈正锐 一种跌打酒
DE10242138A1 (de) 2001-09-13 2003-06-12 Tilman Koehler Mittel zur Pflege und Behandlung der Haut
CN1167451C (zh) 2002-01-17 2004-09-22 王树棠 治疗烫火伤的外用药及其生产方法和药中应用
US7655717B2 (en) 2002-07-17 2010-02-02 Mary J. Goulbourne Ointment composition for treating decubitus ulcers and methods for its making and its use
CN1172712C (zh) 2002-10-25 2004-10-27 仇更生 一种治疗烧伤的乳液
BG730Y1 (bg) * 2003-03-20 2005-04-30 Владимир НАЙДЕНОВ Ефервесцентна лекарствена форма
BG107649A (en) * 2003-03-20 2003-08-29 Владимир НАЙДЕНОВ Effervescent medicamentous form
CN1251730C (zh) 2004-03-01 2006-04-19 福建省泉州亚泰制药有限公司 一种治疗烧伤药品的生产工艺
EP1740196B1 (en) * 2004-03-23 2015-08-26 Lifeline Nutraceuticals Corporation Compositions and method for alleviating inflammation and oxidative stress in a mammal
CN1679643A (zh) 2004-04-06 2005-10-12 上海银龙医药研究所 芦荟护创凝胶及其制备方法和应用
NZ534973A (en) * 2004-08-27 2006-06-30 Bomac Research Ltd Intramammary formulations
JP2006063038A (ja) * 2004-08-30 2006-03-09 Yukihiro Hirose 老化防止組成物およびそれを含有する化粧料ならびに飲食品
JP2006069948A (ja) * 2004-09-01 2006-03-16 Yukihiro Hirose 老化防止組成物およびそれを含有する化粧料ならびに飲食品
ES2258384B1 (es) * 2005-02-07 2007-07-01 Marina A. Resneeva Producto de aplicacion topica para el tratamiento de la calvicie y enfermedades cutaneas.
US20080050456A1 (en) * 2006-08-23 2008-02-28 Wayne Frederick Leech Intramammary formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113841658A (zh) * 2021-10-13 2021-12-28 昆明医科大学 一种牙周炎模型的快速建立方法及治疗药物

Also Published As

Publication number Publication date
EP2008661A2 (en) 2008-12-31
EP2008661A3 (en) 2009-04-08

Similar Documents

Publication Publication Date Title
AR060847A1 (es) Formulacion a base de calendula, aloe y centella.
ES2361459A8 (es) Gel de quitosano para aplicaciones dermatológicas, proceso de obtención y uso del mismo.
AR044872A1 (es) Composicion pulverizable que comprende un activo farmaceutico al menos una silicona volatil y una fase aceitosa no volatil
WO2015184127A3 (en) Stable cannabinoid formulations
BRPI0700148A (pt) emulsões cosméticas de baixa viscosidade e estabilidade prolongada, de preparação a frio
WO2013178701A3 (de) Zusammensetzungen enthaltend fettalkohole, kationische tenside und n-acyl-n-methylglucamine
AR065318A1 (es) Formulaciones liquidas de formacion de pelicula dermal para liberacion de droga a la piel
ES2478264T3 (es) Glicerosomas y uso de estos en preparaciones farmacéuticas y cosméticas para aplicación tópica
TR200701489A2 (tr) Kozmetik formülasyonlar
RS54507B1 (en) NOSE SPRAY
EA201170543A1 (ru) Жидкий фармацевтический состав, содержащий парацетамол
CL2012003038A1 (es) Polietilenglicol conjugado a factor viia; composicion farmacéutica que comprende dicho polietilenglicol conjugado a factor viia; uso de una composicion farmaceutica para tratar enfermedad o trauma de la coagulacion de la sangre en un paciente que la necesita; proceso para preparar el siguiente polietilenglicol conjugado a factor viia.
AU2016222343A1 (en) Compositions and methods for treating blackheads
CO6660486A2 (es) Composición tópica famacéutica o cosmética útil para el tratamiento de enfermedades o condiciones que cursan con un déficit de la maduración de la envoltura córnea
ES2497667T3 (es) Sistema de emulsificación para usar en cosméticos
AR066814A1 (es) Nuevo humectante y su utilizacion
PH12018500910A1 (en) Novel method of use and compositions
PE20081794A1 (es) Composicion farmaceutica que comprende un agente calcilitico
JP2016514712A5 (es)
UY29989A1 (es) Composiciones farmacéuticas de agentes hipnoticos de accion corta en forma de liberación modificada y los procedimientos para preparar dichas formulaciones
MX2012010935A (es) Formulacion acuosa estable mejorada de (e)-4-carboxiestiril-4-clor obencil sulfona.
AR080633A1 (es) Composiciones dermatologicas que contienen una asociacion de lipidos peroxidados y de zinc, y sus utilizaciones, principalmente, en el tratamiento del herpes. dispositivo medico.
PA8802001A1 (es) Combinación antiretroviral novedosa
Varothai et al. An investigator‐blinded, randomized, prospective, comparative study of efficacy of four anti‐inflammatory and barrier hand moisturizers in patients with chronic hand dermatitis.
JP2011032193A (ja) シート状化粧料

Legal Events

Date Code Title Description
FB Suspension of granting procedure